Epidemiology of Non-Hodgkin Lymphoma

Ferlay J, et al. GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]; 2010. <http://globocan.iarc.fr>.

Swerdlow S, et al. WHO classification of tumours of haematopoietic and lymphoid tissues, vol. 4. Lyon; 2008. p. 439.

Liu, 2003, Increasing incidence of non-Hodgkin’s lymphoma in Canada, 1970–1996: age-period-cohort analysis, Hematol Oncol, 21, 57, 10.1002/hon.703

Hartge, 1992, Quantification of the impact of known risk factors on time trends in non-Hodgkin’s lymphoma incidence, Cancer Res, 52, 5566s

Wang, 2010, Epidemiology in non-Hodgkin lymphoma

Canadian Cancer Society’s Steering Committee on Cancer Statistics, CCS 2012. Toronto, ON; 2012.

Howlader, 2009

Ellison, 2011, Conditional survival analyses across cancer sites. Health reports/statistics Canada, Canadian centre for health information=rapports sur la sante/statistique Canada, Centre canadien d’information sur la sante, 22, 21

Cancer Care Ontario, Cancer in Young Adults in Canada. Toronto, Canada; 2006.

Anderson, 1998, Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s lymphoma classification project, Ann Oncol, 9, 717, 10.1023/A:1008265532487

Ulrickson, 2012, Epidemiology, diagnosis, and treatment of HIV-associated non-Hodgkin lymphoma in resource-limited settings, Adv Hematol, 2012, 932658, 10.1155/2012/932658

Muller, 2005, Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology, Ann Hematol, 84, 1, 10.1007/s00277-004-0939-7

Emmanuel, 2011, African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers, Am J Trop Med Hyg, 84, 397, 10.4269/ajtmh.2011.10-0450

Roman, 2011, Epidemiology of lymphomas, Histopathology, 58, 4, 10.1111/j.1365-2559.2010.03696.x

Nogai, 2011, Pathogenesis of non-Hodgkin’s lymphoma, J Clin Oncol, 29, 1803, 10.1200/JCO.2010.33.3252

Morton, 2006, Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001, Blood, 107, 265, 10.1182/blood-2005-06-2508

Koshiol, 2011, Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin’s lymphoma in veterans from the United States, J Clin Oncol, 29, 378, 10.1200/JCO.2010.30.1515

Au, 2005, Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia, Br J Haematol, 128, 792, 10.1111/j.1365-2141.2005.05387.x

Ansell, 2011, Non-Hodgkin lymphoma and autoimmunity: does gender matter?, Int J Cancer, 129, 460, 10.1002/ijc.25680

Czene, 2007, Sex- and kindred-specific familial risk of non-Hodgkin’s lymphoma, Cancer Epidemiol, Biomarkers Prevent: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 16, 2496, 10.1158/1055-9965.EPI-07-0163

Wang, 2007, Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the International Lymphoma Epidemiology Consortium (InterLymph), Blood, 109, 3479, 10.1182/blood-2006-06-031948

Fernberg, 2010, Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma, Cancer Causes Control: CCC, 21, 759, 10.1007/s10552-010-9504-y

Goldin, 2009, Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia, Haematologica, 94, 647, 10.3324/haematol.2008.003632

Filipovich, 1992, Primary immunodeficiencies: genetic risk factors for lymphoma, Cancer Res, 52, 5465s

Grulich, 2000, B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin’s lymphoma in people with AIDS, AIDS (London, England), 14, 133, 10.1097/00002030-200001280-00008

Biggar, 2007, AIDS-related cancer and severity of immunosuppression in persons with AIDS, J Natl Cancer Inst, 99, 962, 10.1093/jnci/djm010

Dal Maso, 2001, Epidemiology of AIDS-related tumours in developed and developing countries, Eur J Cancer, 37, 1188, 10.1016/S0959-8049(01)00120-4

Opelz, 2004, Lymphomas after solid organ transplantation: a collaborative transplant study report, Am J Transplant, 4, 222, 10.1046/j.1600-6143.2003.00325.x

Zintzaras, 2005, The risk of lymphoma development in autoimmune diseases: a meta-analysis, Arch Int Med, 165, 2337, 10.1001/archinte.165.20.2337

Cogliano, 2011, Preventable exposures associated with human cancers, J Natl Cancer Inst, 103, 1827, 10.1093/jnci/djr483

Young, 2004, Epstein-Barr virus: 40years on, Nat Rev Cancer, 4, 757, 10.1038/nrc1452

Jeang, 2004, Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation, J Biol Chem, 279, 31991, 10.1074/jbc.R400009200

Carbone, 2009, HIV-associated lymphomas and gamma-herpesviruses, Blood, 113, 1213, 10.1182/blood-2008-09-180315

Isaacson, 2005, Update on MALT lymphomas, Best Practice Res: Clin Haematol, 18, 57, 10.1016/j.beha.2004.08.003

Negri, 2004, B-cell non-Hodgkin’s lymphoma and hepatitis C virus infection: a systematic review, Int J Cancer, 111, 1, 10.1002/ijc.20205

Marcucci, 2011, Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities, Blood, 117, 1792, 10.1182/blood-2010-06-275818

Geyer, 2010, Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study, Cancer, 116, 2993, 10.1002/cncr.25114

Morton, 2005, Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph), Cancer Epidemiol Biomarkers Prevent, 14, 925, 10.1158/1055-9965.EPI-04-0693

Bell, 1995, Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers, J Natl Cancer Inst, 87, 223, 10.1093/jnci/87.3.223

Finucane, 2011, National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants, Lancet, 377, 557, 10.1016/S0140-6736(10)62037-5

Larsson, 2011, Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies, Eur J Cancer, 47, 2422, 10.1016/j.ejca.2011.06.029

Erber, 2009, Dietary patterns and the risk of non-Hodgkin lymphoma: the multiethnic cohort, Leukemia Lymphoma, 50, 1269, 10.1080/10428190903030841

Morton, 2005, Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis, Lancet Oncol, 6, 469, 10.1016/S1470-2045(05)70214-X

Scott, 2011, Trichloroethylene and cancer: systematic and quantitative review of epidemiologic evidence for identifying hazards, Int J Environ Res Public Health, 8, 4238, 10.3390/ijerph8114238

Neasham, 2011, Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC), Occup Environ Med, 68, 77, 10.1136/oem.2009.048173

Alexander, 2010, Benzene exposure and non-Hodgkin lymphoma: a meta-analysis of epidemiologic studies, J Occup Environ Med/Am Coll Occup Environ Med, 52, 169, 10.1097/JOM.0b013e3181cc9cf0

Hardell, 2003, Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures?, Environ Health Perspect, 111, 1704, 10.1289/ehp.6270

Ng, 2010, Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma, Cancer Causes Control: CCC, 21, 11, 10.1007/s10552-009-9429-5

Bertrand, 2010, Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men, Epidemiology (Cambridge, Mass.), 21, 172, 10.1097/EDE.0b013e3181cb610b

Negri, 2010, Sun exposure, vitamin D, and risk of Hodgkin and non-Hodgkin lymphoma, Nutr Cancer, 62, 878, 10.1080/01635581.2010.509535

Kricker, 2008, Personal sun exposure and risk of non-Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium, Int J Cancer, 122, 144, 10.1002/ijc.23003